Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05653765

Prognostic Value of the AMR Measured After PPCI in STEMI Patients

Conditions: Coronary Heart Disease, ST Elevation Myocardial Infarction

Sex: All
Ages: 18 Years – N/A
Enrollment: 3000
Sponsor: Henan Institute of Cardiovascular Epidemiology

Location: China

Summary

The goal of this observational study is to learn about in STEMI with Primary PCI Patients. The main questions it aims to answer are:To determine the value of AMR in predicting the long-term clinical prognosis of patients with STEMI after PPCI, and to find the best cut-off value.Analyze the factors of PPCI affecting AMR and explore the effective measures of PPCI microcirculation protection.Radiographic images of STEMI receiving primary PCI treatment in several chest pain centers in China will be included. The last image of the infarct-related vessel will be used as a target to calculate its AMR. The relationship between AMR and long-term clinical prognosis was analyzed.

Eligibility Criteria

Inclusion Criteria:Aged 18 or olderType 1 myocardial infarctionReceive PPCIExclusion Criteria:Failed to identify culprit vessels.Structural heart disease with moderate to severe aortic valve or mitral regurgitation and or stenosis that may affect cardiac functionDialysis patients with severe renal insufficiencySevere and uncontrollable arrhythmiaComplicated with dilated cardiomyopathyUnable to tolerate dual antiplatelet therapySevere and uncontrollable anemiaHyperthyroidismTIMI blood flow 0-1 grade after PPCI

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05653765). StuddyBuddy aggregates publicly available trial information.